Back to Search
Start Over
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis
- Source :
- Annals of Coloproctology, Vol 36, Iss 1, Pp 22-29 (2020)
- Publication Year :
- 2020
- Publisher :
- Korean Society of Coloproctology, 2020.
-
Abstract
- Purpose This study aimed to assess the evaluation of clinical outcomes and consequences of complications after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for the peritoneal carcinomatosis (PC) from colorectal cancer. Methods A total 26 patients underwent CRS and HIPEC for PC from colorectal cancer between March 2009 and April 2018. All the patients underwent CRS with the purpose of complete or near-complete cytoreduction. Intraoperative HIPEC was performed simultaneously after the CRS. Mitomycin C was used as chemotherapeutic agent for HIPEC. Results Median disease-free survival was 27.8 months (range, 13.4–42.2 months). Median overall survival was 56.0 months (range, 28.6–83.5 months). The mean peritoneal cancer index (PCI) was 8.73 ± 5.54. The distributions thereof were as follows: PCI
Details
- Language :
- English
- ISSN :
- 22879714 and 22879722
- Volume :
- 36
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Annals of Coloproctology
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.0ed542cee5ee43ba81cb2f31d11574ba
- Document Type :
- article
- Full Text :
- https://doi.org/10.3393/ac.2019.04.30